background
type
facioscapulohumer
muscular
dystrophi
fshd
caus
aberr
myogen
activ
somat
silent
gene
initi
cascad
cellular
event
ultim
lead
fshd
pathophysiolog
therefor
fshd
domin
gainoffunct
diseas
amen
model
overexpress
howev
larg
variabl
patient
popul
typic
progress
skelet
muscl
weak
becom
notic
second
third
decad
life
yet
mani
genet
fshd
individu
develop
symptom
much
later
life
remain
rel
asymptomat
throughout
live
convers
rare
case
fshd
may
present
clinic
prior
yr
age
ultim
manifest
sever
earli
onset
form
diseas
thu
need
control
time
sever
patholog
fshdlike
model
method
recent
describ
line
condit
transgen
mice
develop
myopathi
upon
induct
human
express
skelet
muscl
use
mous
cross
skelet
musclespecif
tamoxifen
induc
line
gener
highli
versatil
bitransgen
mous
model
chronic
lowlevel
express
mild
patholog
induc
develop
sever
fshdlike
patholog
dosedepend
respons
tamoxifen
identifi
condit
reproduc
gener
model
exhibit
mild
moder
sever
pathophysiolog
character
progress
result
assay
mrna
protein
level
fit
strength
global
gene
express
histopatholog
immun
respons
consist
fshdlike
myopath
phenotyp
importantli
identifi
sexspecif
musclespecif
differ
consid
use
model
preclin
studi
conclus
bitransgen
mous
model
express
chronic
low
level
mild
patholog
detect
muscl
weak
onset
progress
moder
sever
patholog
control
via
tamoxifen
inject
provid
consist
readili
screenabl
phenotyp
assess
therapi
target
mrna
protein
thu
fshdlike
mous
model
use
studi
rang
express
patholog
depend
upon
investig
need
control
mosaic
express
addit
complex
genet
epigenet
condit
requir
develop
clinic
fshd
pathogen
mechan
also
unusu
among
neuromuscular
diseas
fshd
autosom
domin
gainoffunct
diseas
pathogen
gene
typic
express
small
fraction
myocyt
ultim
lead
debilit
muscl
patholog
time
may
account
part
common
adult
onset
clinic
symptom
fshd
patient
addit
appear
fshd
patholog
caus
sporad
burst
increas
express
differenti
myocyt
epigenet
suppress
healthi
asymptomat
subject
sinc
cell
syncyti
detriment
effect
aberr
express
may
found
throughout
fshd
myofib
despit
express
initi
restrict
small
percentag
myonuclei
one
time
regardless
express
fshd
myocyt
skelet
muscl
even
burst
still
extrem
rare
highli
variabl
difficult
detect
sinc
transcript
factor
typic
express
healthi
muscl
aberr
express
alter
mrna
profil
numer
gene
myocyt
mani
target
gene
includ
germlin
specif
gene
cleavag
stage
gene
immun
system
regul
normal
express
healthi
myogen
cell
addit
express
ultim
initi
cascad
numer
potenti
detriment
event
includ
disrupt
proteostasi
nonsensemedi
decay
mrna
splice
mechan
alter
myogenesi
induct
apoptosi
chang
either
alon
combin
lead
progress
muscl
cell
death
ultim
patholog
thu
mrna
protein
prime
target
therapeut
intervent
anim
model
fshd
base
express
adult
skelet
muscl
previous
report
gener
flexd
condit
transgen
line
mice
contain
transgen
engin
locu
use
flex
direct
switch
system
bypass
embryon
lethal
leaki
embryon
express
transgen
upon
cremedi
induct
transgen
recombin
express
control
gene
promot
figur
importantli
sinc
mani
element
within
prime
target
sequencebas
therapi
transgen
maintain
exonintron
structur
endogen
human
gene
male
mice
cross
femal
nzg
mice
assess
induct
cremedi
recombin
use
tmx
dosag
regimen
control
bitransgen
mice
treat
tmx
whole
gastrocnemiu
muscl
fix
lacz
fix
facioscapulohumer
muscular
dystrophi
fshd
afflict
femal
male
age
estim
peopl
worldwid
form
fshd
share
common
pathogen
mechan
increas
somat
express
doubl
homeobox
retrogen
caus
loss
stabl
epigenet
repress
chromosom
macrosatellit
array
epigenet
dysregul
locu
caus
larg
delet
array
singl
allel
reduc
repeat
unit
ru
classifi
mutat
gene
encod
repress
epigenet
regul
locu
classifi
addit
form
fshd
requir
permiss
polyadenyl
signal
pa
ci
distal
dysregul
chromosom
array
patholog
ultim
result
aberr
increas
stabl
somat
express
dysregul
mrna
distalmost
ru
gene
encod
sever
altern
mrna
isoform
gener
altern
site
usag
first
exon
howev
length
mrna
pathogen
express
muscl
encod
pair
homeobox
domain
transcript
factor
normal
express
healthi
human
testi
pluripot
cell
cleavagestag
embryo
transcript
program
key
zygot
genom
activ
support
import
role
earli
embryon
develop
adult
somat
cell
healthi
individu
typic
devoid
detect
express
howev
individu
meet
genet
criteria
fshd
express
stabl
mrna
protein
skelet
muscl
aberrantli
activ
embryon
gene
express
profil
ultim
lead
fshd
pathophysiolog
interestingli
low
somat
express
mrna
per
se
necessarili
pathogen
sinc
express
detect
rare
cultur
myogen
cell
muscl
biopsi
healthi
asymptomat
fshd
subject
albeit
level
significantli
lower
equival
cell
tissu
fshdaffect
subject
epigenet
analysi
pathogen
ru
show
stabil
epigenet
repress
correl
diseas
present
among
healthi
subject
togeth
data
support
level
somat
express
induc
affect
epigenet
stabil
region
key
determin
diseas
onset
sever
includ
untransl
region
utr
endogen
pa
distal
auxiliari
element
dae
enhanc
mrna
cleavag
polyadenyl
event
show
flexd
mous
model
cross
appropri
induc
cre
mous
produc
bitransgen
model
chronic
low
level
express
induc
desir
time
develop
sever
patholog
reproduc
recapitul
mani
aspect
fshd
pathophysiolog
importantli
sever
patholog
control
investig
thu
provid
sever
suitabl
model
therapeut
intervent
target
mrna
protein
certain
downstream
pathway
cre
driver
line
refer
jax
nzg
refer
fvbcggt
rosa
caglacz
egfp
glh
j
jax
purchas
jackson
lab
bangor
main
flexd
mice
gener
character
pl
jone
lab
avail
jackson
lab
jax
mice
genotyp
describ
tamoxifen
free
base
sigma
dissolv
ethanol
ad
prewarm
steril
corn
oil
thermofish
make
frozen
stock
stock
tmx
aliquot
warm
dilut
prewarm
steril
corn
oil
either
prior
use
administ
mice
intraperiton
ip
inject
final
concentr
moder
model
flexd
bitransgen
anim
inject
tmx
sever
model
flexd
bitransgen
mice
inject
two
consecut
day
tmx
glutaraldehyd
egta
pb
hour
cryopreserv
cold
sucrosepb
overnight
frozen
oct
section
cryosect
fix
paraformaldehyd
pfa
pb
stain
xgal
stain
solut
pb
potassium
ferricyanid
potassium
ferrocyanid
nonidet
sodium
deoxychol
xgal
min
stain
section
postfix
buffer
formalin
min
rins
three
time
pb
deioniz
water
mount
imag
captur
use
olympu
microscop
pixelink
camera
bright
field
total
rna
extract
dissect
mous
muscl
homogen
volum
trizol
thermofish
use
tissuelys
lt
qiagen
per
manufactur
instruct
follow
oncolumn
dnasei
treatment
cleanup
use
rneasi
mini
kit
qiagen
quantit
mrna
express
analyz
use
nest
qrtpcr
describ
express
target
gene
analyz
qpcr
use
cdna
describ
oligonucleotid
primer
sequenc
downstream
target
rrna
previous
report
express
myostatin
mrna
analyz
qrtpcr
use
primer
forward
revers
signific
calcul
use
twotail
test
freshli
dissect
muscl
kept
moist
coat
oct
compound
snapfrozen
liquid
nitrogencool
isopentan
store
section
cryosect
mount
slide
airdri
stain
storag
section
use
h
e
stain
picrosiriu
red
stain
sr
stain
perform
describ
cryosect
cut
mid
belli
tibiali
anterior
muscl
fix
pfapb
ph
min
rins
dehydr
seri
min
ethanol
wash
air
dri
section
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
stain
hr
sr
solut
direct
red
satur
picric
acid
wash
three
time
stain
section
dehydr
seri
min
ethanol
wash
clear
xylen
min
mount
seri
micrograph
muscl
section
captur
use
object
leica
reconstitut
form
whole
muscl
crosssect
use
la
softwar
leica
microsystem
inc
whole
crosssect
imag
divid
section
process
matlab
mathwork
determin
number
pixel
stain
red
total
number
pixel
stain
muscl
mice
treatment
analyz
signific
calcul
oneway
anova
use
prism
graphpad
cryosect
muscl
tissu
fix
pfapb
ice
min
permeabil
min
incub
block
solut
normal
goat
serum
bsa
min
incub
primari
antibodi
overnight
follow
day
section
incub
secondari
antibodi
room
temperatur
min
mount
prolong
gold
dapi
nuclear
stain
detect
use
antibodi
abcam
dilut
embryon
fast
myosin
heavi
chain
detect
use
monoclon
antibodi
develop
baxter
lab
stem
cell
biolog
stanford
univers
obtain
development
studi
hybridoma
bank
creat
nichd
nih
maintain
treadmil
test
perform
treadmil
shock
detect
system
columbu
instrument
mous
mode
electr
shock
grid
mice
acclim
apparatu
run
place
unmov
treadmil
min
speed
mmin
min
inclin
mice
rest
day
first
test
exhaust
test
establish
fshdlike
model
mice
sever
modif
treatnmd
protocol
test
perform
use
inclin
initi
speed
mmin
speed
increas
everi
minut
mice
run
unabl
maintain
speed
remain
shock
grid
second
time
fatigu
maximum
min
approxim
maximum
speed
mmin
maximum
distanc
test
perform
least
three
time
per
mous
least
two
day
rest
test
signific
calcul
twoway
anova
use
prism
graphpad
edl
muscl
excis
deepli
anesthet
mice
isofluran
hung
computercontrol
servomotor
aurora
scientif
inc
mount
heat
oxygen
tissu
bath
contain
physiolog
salt
solut
describ
experi
perform
data
analyz
use
dma
softwar
aurora
scientif
inc
prism
graphpad
previous
describ
treatnmd
sop
signific
twitch
tetanu
calcul
oneway
anova
forc
frequenc
analysi
calcul
twoway
anova
use
prism
graphpad
base
pair
singleread
configur
rapid
run
mode
total
least
million
read
per
lane
sequenc
read
trim
remov
adapt
sequenc
poor
qualiti
nucleotid
error
rate
end
sequenc
read
shorter
nucleotid
discard
data
sourc
rnaseq
read
express
control
download
gene
express
omnibu
access
number
genom
annot
read
map
gene
express
estim
human
mous
genom
annot
creat
merg
ucsc
knowngen
ensembl
miso
annot
sequenc
read
map
annot
previous
describ
brief
rsem
modifi
call
bowti
option
v
use
map
read
merg
genom
annot
remain
unalign
read
map
genom
databas
potenti
splice
junction
tophat
gene
express
estim
normal
use
trim
mean
valu
tmm
method
differenti
express
gene
tabl
geo
access
pend
versu
control
experi
defin
threshold
chang
bay
factor
comput
wagenmak
framework
observ
possibl
pairwis
comparison
experiment
replic
go
term
enrich
amongst
gene
exhibit
increas
decreas
express
versu
control
sampl
identifi
goseq
method
falsediscoveri
rate
threshold
go
superterm
immun
immun
chemokin
interferon
wound
viru
cytokin
cytokin
leukocyt
interleukin
tolllik
tolllik
bacteri
inflamma
defens
immunolog
immunoglobulin
receptor
mhc
immunoglobulin
viral
differentiallyexpress
gene
comparison
control
muscl
biopsi
defin
gene
consist
differenti
express
threshold
bay
factor
comput
wagenmak
framework
possibl
pairwis
comparison
control
muscl
intersect
gene
ortholog
differentiallyexpress
mous
gene
vs
control
experi
summar
tabl
data
analysi
visual
data
analysi
perform
r
program
environ
reli
bioconductor
dplyr
venn
diagram
plot
use
venneul
packag
miso
comput
method
use
character
skip
exon
se
retain
intron
ri
altern
splice
event
rnaseq
sampl
tabl
miso
version
execut
map
result
produc
tophat
use
follow
configur
mineventread
burnin
lag
numit
numchain
fshd
caus
mosaic
express
mrna
encod
protein
normal
silent
gene
small
fraction
differenti
adult
skelet
myocyt
previous
show
mosaic
express
skelet
muscl
transgen
mice
flexd
produc
sever
myopathi
fshdlike
patholog
howev
preclin
test
differ
candid
fshd
therapeut
target
mrna
protein
express
mice
like
requir
differ
criteria
degre
progress
pathophysiolog
depend
upon
approach
address
issu
gener
character
highli
reproduc
seri
phenotyp
fshdlike
transgen
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mous
model
vari
sever
pathogen
progress
base
differ
level
mosaic
express
pathogen
mrna
isoform
human
adult
murin
skelet
muscl
identifi
tamoxifen
tmx
induc
skelet
musclespecif
cre
express
transgen
mice
strong
candid
gener
desir
phenotyp
test
could
use
gener
mosaic
express
skelet
muscl
optim
tmx
dose
mice
cross
nzg
cre
report
mice
produc
readili
detect
nuclear
nlacz
express
cell
cre
function
nucleu
figur
two
dose
regimen
tmx
test
nzg
bitransgen
offspr
singl
low
dose
intraperiton
ip
inject
two
ip
inject
consecut
day
higher
dose
express
nlacz
report
gene
visual
xgal
stain
gastrocnemiu
muscl
isol
two
week
tmx
inject
result
indic
dose
regimen
produc
mosaic
pattern
cremedi
recombin
skelet
muscl
high
tmx
dose
produc
xgal
stain
nuclei
low
dose
figur
surprisingli
absenc
tmx
nzg
mice
also
show
transgen
recombin
although
small
fraction
skelet
muscl
nuclei
figur
interestingli
lowlevel
recombin
nlacz
express
uniform
across
nuclei
rather
also
show
mosaic
pattern
recombin
onethird
number
recombin
nuclei
induc
low
tmx
dose
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
differ
level
mosaic
transgen
recombin
genom
dna
isol
day
postinject
dpi
tmx
assay
transgen
recombin
genom
pcr
figur
flexd
hemizyg
mice
show
transgen
recombin
absenc
cre
bitransgen
anim
show
variabl
low
level
transgen
recombin
skelet
muscl
heart
liver
absenc
tmx
due
abovement
sporad
leaki
nuclear
cre
activ
mice
inject
tmx
induc
cre
nuclear
activ
stimul
transgen
recombin
skelet
muscl
bitransgen
mice
show
increas
recombin
respons
low
tmx
dose
even
higher
level
recombin
respons
high
tmx
dose
surprisingli
three
bitransgen
model
low
high
tmx
musclespecif
differ
transgen
recombin
rate
howev
differ
consist
tmx
treat
line
figur
exampl
quadricep
muscl
show
lowest
recombin
tmxinduc
model
follow
tibiali
anterior
ta
gastrocnemiu
muscl
intermedi
level
diaphragm
soleu
show
highest
recombin
level
expect
use
driver
line
heart
liver
show
transgen
recombin
bitransgen
anim
sinc
assay
measur
transgen
recombin
singl
copi
transgen
per
nucleu
result
show
less
recombin
repres
mosaic
recombin
translat
desir
mosaic
transgen
express
conclud
identifi
three
condit
reproduc
produc
differ
level
mosaic
transgen
recombin
refer
mild
moder
sever
tabl
base
subsequ
character
describ
importantli
futur
studi
show
differ
skelet
muscl
show
differ
level
recombin
respons
tmx
treatment
assess
variabl
rate
transgen
recombin
model
translat
similarli
variabl
level
protein
express
singl
nucleu
level
muscl
tissu
analyz
immunofluoresc
use
antibodi
mosaic
pattern
nuclear
express
readili
detect
cross
section
ta
muscl
three
model
figur
bitransgen
flexd
mice
show
posit
nuclei
absenc
tmx
figur
n
consist
low
level
transgen
recombin
figur
howev
sinc
cytotox
known
long
express
cell
may
remain
muscl
time
cours
studi
perform
tmxinject
mice
lowdos
mice
appear
moder
affect
phenotyp
time
refer
moder
fshdlike
model
tabl
discuss
detail
assay
dpi
express
appear
dpi
moder
day
peak
greatli
reduc
like
due
death
cell
figur
j
mice
inject
highdos
tmx
regimen
sever
affect
dpi
sacrif
could
assess
mice
refer
sever
fshdlike
model
similarli
show
express
three
day
first
inject
sever
day
peak
express
overal
bitransgen
mice
without
tmx
refer
mild
fshdlike
model
exhibit
low
number
myonuclei
moder
model
exhibit
increas
number
sever
model
highest
number
protein
detect
heart
skelet
muscl
nonrecombin
order
quantit
chang
gene
express
sever
model
qrtpcr
use
measur
overal
mrna
level
figur
howev
previous
shown
assay
poor
measur
transgen
express
use
mous
model
mrna
even
difficult
detect
muscl
biopsi
fshd
affect
subject
sinc
function
transcript
activ
human
mous
cell
express
direct
target
gene
proven
accur
indic
express
level
speci
therefor
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
addit
mrna
mrna
level
two
mous
homolog
direct
target
gene
also
assay
figur
c
detect
mrna
level
extrem
low
gastrocnemiu
muscl
model
figur
consist
previou
studi
interestingli
signific
chang
detect
mrna
level
mild
moder
sever
model
day
tmx
treatment
timepoint
promin
differ
protein
express
figur
contrast
target
gene
assay
show
signific
induct
bitransgen
anim
compar
flexd
mice
indic
presenc
protein
mrna
level
significantli
increas
muscl
moder
sever
model
compar
mild
model
mrna
level
significantli
increas
sever
model
compar
moder
model
figur
c
conclud
bitransgen
mice
show
increas
express
correl
degre
tmx
treatment
resembl
fshd
patient
muscl
biopsi
show
increas
express
known
target
gene
compar
control
biopsi
determin
increas
protein
target
gene
express
level
skelet
muscl
correl
alter
muscl
function
strength
perform
treadmil
exhaust
assay
ex
vivo
muscl
physiolog
studi
adult
control
bitransgen
mice
show
size
differ
male
bitransgen
male
significantli
smaller
control
respect
figur
femal
genotyp
show
signific
size
differ
prior
tmx
inject
respect
figur
c
therefor
male
femal
mice
analyz
separ
assess
potenti
sex
differ
present
phenotyp
treadmil
analysi
protocol
consist
run
mice
slightli
inclin
treadmil
slowli
increas
speed
mice
could
run
longer
measur
time
fatigu
maximum
assay
time
min
found
particular
condit
see
method
provid
highli
consist
result
readili
assay
window
three
mous
model
male
femal
control
mice
inject
appropri
tmx
dose
group
assay
show
steadi
level
near
maximum
treadmil
run
fit
min
cours
assay
figur
blue
line
similarli
treadmil
fit
male
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
femal
bitransgen
mice
significantli
differ
control
figur
green
line
howev
male
femal
mice
inject
tmx
produc
either
moder
level
patholog
tmx
sever
level
patholog
tmx
significantli
less
fit
compar
control
figur
red
line
interestingli
moder
sever
model
show
sexspecif
treadmil
fit
profil
femal
mice
figur
c
sever
affect
male
mice
figur
moder
femal
mice
show
signific
declin
fit
day
tmx
induct
drop
near
maximum
run
time
less
minut
declin
remain
begin
recov
min
run
min
comparison
male
moder
model
mice
show
signific
declin
start
run
min
progress
slowli
femal
run
min
min
recov
min
overal
although
moder
affect
mice
show
signific
declin
treadmil
fit
cours
four
week
femal
mice
sever
affect
recov
slowli
male
mice
sever
model
mice
femal
mice
declin
rapidli
male
although
show
signific
declin
run
time
fatigu
decreas
min
compar
control
point
moder
model
mice
still
unaffect
femal
mice
could
even
begin
assay
male
counterpart
slightli
less
fatigu
abl
run
second
male
mice
reach
point
unabl
safe
start
assay
assay
point
indic
much
sever
phenotyp
point
assess
moder
model
sever
affect
mice
human
sacrif
gener
movement
cage
greatli
impair
sign
recoveri
sexspecif
differ
make
vital
import
analyz
compar
mice
sex
perform
fit
assay
use
fshdlike
model
treadmil
assay
indic
muscl
use
andor
function
impair
induct
express
moder
sever
mous
model
ex
vivo
muscl
contractil
studi
use
isol
extensor
digitorum
longu
edl
perform
mice
assess
chang
muscl
strength
muscl
forc
isometr
contract
twitch
tetan
tetan
forc
chang
increas
frequenc
electr
stimul
forc
frequenc
measur
muscl
stiff
calcul
analysi
eccentr
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
contract
figur
edl
muscl
isol
mild
model
bitransgen
mice
tmx
initi
compar
agematch
mice
control
treat
appropri
dose
tmx
respect
group
isol
tmx
tmx
first
inject
interestingli
despit
similar
treadmil
endur
profil
control
figur
femal
bitransgen
mice
tmx
consist
show
significantli
lower
maximum
absolut
forc
specif
forc
measur
maximum
forc
normal
cross
section
area
csa
compar
control
figur
male
bitransgen
mice
howev
less
affect
show
signific
strength
differ
control
respect
maximum
twitch
forc
maximum
forc
frequenc
figur
f
signific
chang
specif
forc
measur
howev
male
femal
bitransgen
mild
model
significantli
less
respons
midlevel
high
stimul
frequenc
hz
compar
control
figur
conclud
chronic
low
mosaic
express
even
myofib
reproduc
produc
measur
decreas
isometr
contractil
strength
muscl
appear
affect
treadmil
fit
thu
data
suggest
mild
bitransgen
tmx
mice
may
present
model
presymptomat
fshd
earli
symptomat
mild
fshd
similarli
assay
moder
sever
bitransgen
mous
model
ex
vivo
muscl
function
show
signific
differ
treadmil
fit
compar
control
mild
model
mice
upon
tmx
inject
figur
e
moder
model
analysi
femal
mice
run
treadmil
exhaust
prior
tmx
inject
run
twice
per
week
sacrif
assay
peak
protein
express
figur
impair
treadmil
run
figur
moder
model
isol
edl
muscl
moder
model
mice
significantli
weaker
stiffer
compar
control
figur
howev
muscl
show
small
signific
decreas
specif
forc
measur
stiff
compar
mild
bitransgen
mice
impair
muscl
function
much
strike
sever
bitransgen
model
mice
male
femal
mice
run
treadmil
exhaust
prior
tmx
inject
femal
male
sacrif
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
decreas
specif
forc
measur
muscl
significantli
stiffer
eccentr
stretch
compar
control
bitransgen
mild
model
mice
addit
sever
model
mice
virtual
nonrespons
low
frequenc
stimuli
sever
impair
across
forc
frequenc
assay
rang
figur
compar
moder
model
mice
muscl
sever
model
significantli
weaker
overal
conclud
murin
skelet
muscl
toler
low
level
express
without
signific
impair
function
howev
increas
express
eventu
lead
muscl
weak
loss
function
dosedepend
manner
begin
identifi
mechan
pathway
disrupt
express
murin
skelet
muscl
rnaseq
analysi
perform
gastrocnemiu
muscl
isol
control
moder
sever
model
mice
analyz
mrna
express
level
tabl
gene
signific
differenti
express
control
identifi
tabl
flexd
singl
transgen
mice
show
gene
differenti
express
upregul
downregul
mice
figur
tabl
consist
previou
qrtpcr
studi
show
signific
differ
express
sever
promin
target
mice
contrast
transcriptom
moder
sever
model
significantli
differ
control
analyz
gene
significantli
misregul
figur
c
tabl
howev
gene
murin
skelet
muscl
compar
differenti
gene
express
profil
human
fshd
patient
muscl
biopsi
littl
overlap
upregul
gene
downregul
gene
tabl
surpris
sinc
human
express
cultur
mous
cell
induc
gene
set
partial
overlap
express
cultur
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
human
cell
mani
function
bind
site
human
genom
within
poorli
conserv
retroel
despit
low
overlap
specif
misregul
gene
muscl
fshd
patient
fshdlike
mice
conserv
pathway
human
mous
gener
myopath
phenotyp
appear
conserv
across
sever
speci
proapoptot
express
detriment
muscl
develop
differenti
express
stimul
gene
modul
immun
respons
fshd
patient
biopsi
show
express
immun
gene
featur
inflamm
visual
mri
immun
cell
infiltr
therefor
perform
gene
ontolog
go
enrich
analysi
differenti
express
gene
fshdlike
moder
sever
mous
model
tabl
gene
enrich
comparison
list
tabl
express
shown
inhibit
nonsensemedi
decay
result
accumul
mrna
would
typic
substrat
nmd
therefor
analyz
rnaseq
data
aberr
altern
splice
event
result
skip
exon
se
retain
intron
ri
use
miso
miso
identifi
altern
splice
event
base
predefin
splice
event
take
advantag
exist
knowledg
therefor
accur
character
altern
splice
event
rnaseq
data
miso
analysi
rnaseq
data
reveal
moder
sever
diseas
model
signific
increas
se
ri
event
sever
model
significantli
se
ri
event
moder
model
tabl
data
support
increas
express
increas
diseas
sever
correl
increas
se
ri
suggest
decreas
rna
qualiti
control
tabl
histolog
analysi
fshdlike
model
mice
three
sever
level
myopath
mous
phenotyp
tabl
analyz
histopatholog
initi
analysi
mous
model
show
differ
musclespecif
level
transgen
recombin
three
bitransgen
sever
model
figur
therefor
cryosect
histolog
analysi
gener
multipl
muscl
includ
ta
gastrocnemiu
soleu
quadricep
heart
three
model
muscl
section
analyz
hematoxylin
eosin
h
e
stain
assess
fiber
morpholog
tunel
assay
assess
apoptosi
embryon
myosin
heavi
chain
assess
muscl
fiber
regener
picrosiriu
red
sr
stain
assess
fibrosi
assess
immun
cell
infiltr
previous
describ
timecours
treadmil
exhaust
run
perform
use
femal
mice
moder
model
figur
importantli
seen
mild
model
model
show
anatom
musclespecif
differ
histopathogen
featur
correl
musclespecif
level
transgen
recombin
figur
consist
express
lead
atroph
phenotyp
exampl
soleu
muscl
show
highest
level
tmxrespons
transgen
recombin
also
appear
greatest
degre
histopatholog
model
includ
mononuclear
cell
infiltr
disrupt
muscl
integr
figur
figur
fiber
central
nuclei
figur
quadricep
show
lowest
level
transgen
recombin
similarli
show
least
amount
histopatholog
analyz
skelet
muscl
heart
show
transgen
recombin
express
show
patholog
even
sever
model
figur
overal
skelet
muscl
histopatholog
model
progress
appear
peak
express
level
moder
model
appear
earlier
sever
model
peak
level
support
extent
patholog
mous
model
correl
level
transgen
recombin
figur
express
figur
central
posit
nuclei
myofib
common
featur
mani
myopathi
consid
sign
repair
regener
myofib
interestingli
three
sever
model
fshdlike
mice
show
increas
central
nuclei
especi
follow
induct
figur
therefor
analyz
muscl
model
express
emyhc
protein
figur
marker
newli
regener
myofib
dystroph
muscl
express
myostatin
mstn
figur
neg
regul
muscl
growth
remodel
adult
muscl
adult
mous
skelet
muscl
myofib
express
emyhc
isoform
normal
healthi
condit
howev
regener
myofib
reexpress
mani
development
isoform
muscl
protein
includ
emyhc
detect
within
day
injuri
whose
express
persist
week
therefor
time
cours
studi
emyhc
express
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
induct
perform
ta
muscl
figur
expect
control
show
detect
express
emyhc
respons
tmx
figur
interestingli
mild
model
bitransgen
mice
low
mosaic
express
similarli
show
detect
express
emyhc
figur
l
indic
myofib
central
nuclei
mild
model
remnant
old
regener
event
contrast
moder
model
figur
j
sever
model
figur
r
show
high
level
emyhc
peak
respect
thu
confirm
spike
express
moder
sever
level
activ
skelet
muscl
regener
program
contrast
emyhc
level
express
mstn
mrna
decreas
ta
muscl
level
sever
patholog
increas
figur
togeth
result
show
increas
express
lead
muscl
remodel
regener
activ
muscl
fiber
regener
induct
express
suggest
caus
muscl
damag
go
analysi
differenti
induc
gene
show
muscl
moder
sever
model
enrich
gene
apoptot
pathway
figur
tabl
mention
proapoptot
protein
express
highli
toxic
muscl
cell
cultur
apoptosi
featur
fshd
muscl
assess
apoptosi
fshdlike
model
tunel
assay
perform
ta
muscl
across
induct
timecours
moder
sever
model
figur
respect
moder
model
tunelposit
nuclei
appear
preval
nearli
absent
figur
similarli
sever
model
show
tunel
posit
nuclei
dramat
increas
figur
interestingli
muscl
bitransgen
mild
model
show
indic
apoptosi
similar
muscl
control
compar
panel
l
thu
moder
sever
model
show
dosedepend
apoptosi
follow
similar
time
cours
muscl
weak
decreas
function
correl
activ
muscl
regener
fshd
muscl
similarli
rnaseq
analysi
muscl
moder
sever
fshdlike
mous
model
indic
enrich
immun
respons
gene
figur
h
e
stain
show
mononuclear
cell
infiltr
induct
appear
histopatholog
figur
therefor
mononuclear
cell
infiltr
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
gastrocnemiu
muscl
moder
figur
sever
figur
model
assay
time
cours
induct
muscl
section
immunostain
itgam
integrin
subunit
alpha
member
integrin
famili
leukocyt
adhes
receptor
involv
leukocyt
migrat
lymphocyt
antigen
complex
locu
g
marker
murin
neutrophil
figur
c
respect
importantli
immun
phenotyp
moder
sever
model
consist
patholog
seen
muscl
clinic
affect
fshd
patient
lack
immun
cell
infiltr
mild
model
consist
lack
overt
patholog
presymptomat
asymptomat
fshd
subject
patient
muscl
fibrosi
deposit
extracellular
matrix
myofib
anoth
featur
mani
muscular
dystrophi
includ
fhsd
lead
loss
muscl
architectur
decreas
muscl
function
inflammatori
cell
present
fshdlike
mous
model
figur
abl
stimul
fibrot
activ
regener
promot
fibrot
tissu
remodel
extent
fibrosi
typic
quantifi
use
histolog
method
stain
collagen
therefor
cross
section
ta
muscl
isol
seri
control
mild
moder
sever
fshdlike
mice
assay
extent
fibrosi
develop
time
use
sr
stain
figur
muscl
control
mild
bitransgen
model
similar
low
level
fibrot
area
fibrosi
figur
f
g
figur
moder
bitransgen
model
similar
control
level
fibrosi
howev
model
show
small
signific
increas
fibrosi
figur
e
figur
sever
bitransgen
model
show
increas
fibrosi
maxim
increas
fibrosi
fibrot
area
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
hj
figur
heart
express
detect
model
show
sign
fibrosi
figur
model
fshd
transgen
mice
histor
difficult
despit
fact
fshd
gainoffunct
diseas
seemingli
amen
transgen
overexpress
human
gene
conserv
development
role
dux
famili
member
found
mammal
includ
mous
signific
diverg
dna
protein
sequenc
level
well
spectrum
speciesspecif
target
gene
addit
highli
cytotox
mani
somat
cell
leaki
express
develop
problemat
surviv
mice
sever
phenotyp
difficult
breed
howev
flexd
mice
recent
develop
overcam
mani
previou
limit
male
femal
mice
fertil
easi
breed
male
femal
transgen
mice
produc
either
transgen
heterozygot
homozygot
live
year
mate
induc
cre
line
mice
bitransgen
mice
allow
investigatorcontrol
express
mrna
protein
result
fshdlike
muscl
patholog
report
character
seri
phenotyp
fshdlike
mous
model
vari
sever
mild
sever
gener
use
flexd
condit
transgen
mous
line
cross
tmxinduc
mice
demonstr
bitransgen
mous
model
without
tmx
induct
recapitul
mani
aspect
fshd
pathophysiolog
variabl
sever
thu
provid
suitabl
model
therapeut
intervent
target
mrna
protein
certain
downstream
pathway
sever
key
caveat
particular
import
work
model
keep
mind
describ
anatom
musclespecif
sexspecif
differ
patholog
diseas
progress
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cre
activ
absenc
tmx
fraction
nuclei
thu
flexd
bitransgen
mice
result
recombin
transgen
low
mosaic
express
protein
skelet
muscl
throughout
lifetim
importantli
although
leaki
recombin
specif
skelet
muscl
uniform
among
skelet
muscl
differ
anatom
muscl
exhibit
differ
consist
level
recombin
thu
express
figur
eg
soleu
low
quadricep
high
thu
situat
mild
model
similar
presymptomat
asymptomat
fshd
patient
mice
live
chronic
lowlevel
mosaic
express
fraction
muscl
fiber
yet
phenotyp
mice
appear
healthi
behav
normal
chang
overal
fit
lifespan
although
mild
mice
appear
outwardli
healthi
lowlevel
recombin
produc
sever
assay
phenotyp
mild
phenotyp
manifest
increas
express
target
gene
figur
decreas
express
mstn
figur
myofib
central
nuclei
week
age
figur
decreas
capac
muscl
forc
gener
femal
male
mice
assay
ex
vivo
figur
also
small
signific
differ
male
femal
respect
histolog
central
nuclei
need
taken
account
overal
lowlevel
muscl
patholog
new
fiber
regener
howev
mice
exhibit
increas
apoptosi
immun
cell
infiltr
increas
fibrosi
model
readili
scalabl
highli
reproduc
consid
mice
live
femal
male
provid
express
model
amen
longev
studi
efficaci
put
therapeut
thu
mild
model
like
easiest
work
impos
time
limit
treatment
investig
care
choos
sex
use
use
signific
number
sex
analyz
separ
age
use
muscl
assay
treat
similar
modelspecif
effect
need
taken
account
inject
tmx
gener
moder
sever
model
even
pronounc
importantli
moder
model
show
consist
differ
level
tmxinduc
recombin
anatom
muscl
figur
differ
leaki
recombin
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mild
model
like
reflect
differ
tmx
access
variou
muscl
moder
model
mice
also
show
signific
differ
male
femal
respect
weight
figur
treadmil
profil
figur
muscl
physiolog
figur
femal
sever
affect
metric
respect
appear
progress
patholog
mice
show
reduct
mstn
express
oppos
mild
model
moder
model
mice
apoptosi
figur
recruit
immun
cell
damag
muscl
figur
protein
express
apoptosi
immun
cell
recruit
peak
point
also
increas
emyhc
posit
newli
regener
fiber
well
fibrosi
figur
muscl
stage
produc
forc
produc
control
figur
analysi
global
differenti
gene
express
support
activ
apoptosi
immun
respons
cell
cycl
three
much
larger
group
enrich
cell
express
illustr
key
differ
perform
studi
vitro
use
singl
cell
type
overexpress
compar
studi
intact
muscl
express
mosaic
level
contain
associ
cell
type
figur
key
compon
moder
model
male
femal
mice
recov
regain
treadmil
run
coincid
decreas
apoptosi
emyhc
stain
immun
cell
infiltr
although
fibrosi
remain
like
posit
myofib
die
repair
replac
use
satellit
cell
undergo
transgen
recombin
thu
activ
express
therefor
imper
proper
control
use
model
preclin
test
therapeut
howev
also
present
opportun
wherebi
mice
reinject
tmx
point
treatment
progress
declin
model
assess
sever
month
preliminari
experi
lab
suggest
viabl
possibl
need
investig
character
addit
tmx
adjust
singl
higherdos
inject
multipl
lowerdos
inject
refin
model
meet
investig
need
flexibl
tunabl
model
almost
endless
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
moder
model
assay
cours
month
sever
model
use
shortterm
analys
patholog
sever
mice
requir
sacrific
later
mice
show
sign
recoveri
moder
model
consist
differ
level
transgen
recombin
express
among
differ
anatom
muscl
figur
howev
differ
muscl
show
pattern
moder
model
eg
soleu
highest
quadricep
lowest
model
support
idea
access
tmx
respons
variabl
addit
seen
mild
moder
model
femal
male
sever
model
show
sexspecif
differ
femal
sever
affect
goal
studi
gener
three
level
fshdlike
sever
use
mous
model
character
progress
patholog
way
use
perform
preclin
test
candid
therapeut
provid
initi
molecular
phenotyp
physiolog
histolog
character
three
sever
level
induc
fshdlike
model
mice
key
featur
model
flexd
bitransgen
mice
express
chronic
lowlevel
mosaic
skelet
musclespecif
mrna
protein
thu
moder
sever
model
introduc
express
naiv
system
instead
provid
situat
similar
burst
express
seen
fshd
myocyt
welldocu
cell
asymptomat
fshd
subject
express
cell
rel
healthi
muscl
biopsi
clinic
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
affect
fshd
patient
express
signific
level
thu
model
recapitul
envis
situat
fshd
wherebi
genet
fshd
patient
express
low
level
skelet
muscl
point
level
significantli
increas
along
muscl
patholog
bitransgen
fshdlike
model
allow
investig
recapitul
chronic
lowlevel
follow
investigatorcontrol
increas
express
accompani
patholog
whatev
degre
desir
overal
dosedepend
fshdlike
phenotyp
mous
model
strongli
support
misexpress
model
mediat
fshd
pathogenesi
provid
use
highli
flexibl
tool
perform
fshd
preclin
test
therapeut
approach
target
mrna
protein
importantli
futur
analys
shown
sexspecif
differ
anatom
musclespecif
differ
modelspecif
differ
must
taken
account
use
fshdlike
mice
within
singl
mous
one
assess
differenti
affect
muscl
studi
sex
cross
provid
finetun
effect
well
femal
slightli
significantli
affect
male
provid
even
greater
flexibl
util
model
tool
studi
fshd
test
potenti
therapeut
approach
ethic
approv
anim
procedur
approv
local
iacuc
committe
univers
nevada
reno
avail
data
materi
data
gener
analyz
studi
includ
manuscript
supplement
data
data
includ
avail
correspond
author
upon
request
raw
rnaseq
data
gener
studi
deposit
ncbi
gene
express
omnibu
geo
databas
access
number
pend
process
gene
express
data
deposit
geo
access
number
pend
author
declar
compet
interest
myotub
signific
calcul
welch
test
p
p
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mice
weigh
time
cours
tmx
treatment
prior
treadmil
run
figur
moder
affect
femal
mice
red
line
assay
prior
tmx
inject
day
postinject
dpi
compar
agematch
femal
bitransgen
mice
green
line
femal
mice
inject
tmx
blue
line
b
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
moder
affect
male
mice
red
line
assay
prior
tmx
inject
dpi
compar
agematch
male
bitransgen
mice
green
line
male
mice
inject
tmx
blue
line
c
sever
affect
femal
mice
red
line
assay
prior
tmx
inject
dpi
compar
agematch
femal
bitransgen
mice
green
line
mice
inject
tmx
blue
line
sever
affect
male
mice
red
line
assay
prior
tmx
inject
dpi
compar
agematch
male
bitransgen
mice
green
line
mice
inject
tmx
blue
line
number
mice
n
experi
figur
signific
p
p
p
calcul
bitransgen
tmx
bitransgen
tmx
green
tmx
blue
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
specif
maximum
twitch
forc
e
specif
maximum
tetanu
forc
f
specif
forc
frequenc
signific
p
p
p
blue
asterisk
indic
signific
compar
control
mice
green
asterisk
indic
signific
compar
bitransgen
mcm
flexd
mild
model
mice
level
normal
mrna
level
signific
calcul
use
oneway
anova
uncorrect
fisher
lsd
p
p
p
ns
signific
data
plot
percent
fibrot
area
signific
calcul
use
least
signific
differ
test
p
p
p
figur
cardiac
muscl
fshdlike
mous
model
show
sign
increas
fibrosi
heart
isol
mice
assay
figur
skelet
muscl
fibrosi
control
mice
blue
bitransgen
mild
model
mice
green
sever
model
mice
red
show
signific
differ
heart
fibrosi
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
